SOSV

Investment thesis

Deep tech for human and planetary health. Invests in climate tech, health tech, and physical AI solving critical real-world problems through HAX and IndieBio programs.

Focus narrative

Exclusively deep tech with real-world impact. Avoids software-only/pure SaaS. Three pillars: Climate Tech (world's leading climate tech investor, $11.09B portfolio valuation), Health Tech ($6.67B portfolio valuation), Physical AI (intelligent machines that sense, decide, act). Initial checks $250K-$550K at pre-seed; follow-on through $100M Select Fund.

Value beyond capital

HAX program: 85,000 sq ft of labs in SF, NYC, Newark for hard tech prototyping. IndieBio program: wet labs and scientific expertise for biotech. Hands-on engineering, manufacturing, and design support. Supply chain partnerships in Shenzhen and Pune. $100M Select Fund for growth follow-on. Demo days and annual Deep Tech 100 / Climate Tech 100 lists.

Program thesis

Deep tech VC running specialized accelerator programs: HAX (hardware), IndieBio (biotech), Chinaccelerator (Asia), MOX (mobile), dlab (Web3). $1.5B+ AUM. 70% climate tech allocation in Fund V.

Focus narrative

SOSV focuses on replacing humanity's means of production through deep tech. Fund V allocation: 70% climate tech, 25% health tech, 5% opportunistic. Programs by sector: HAX: chemistry, electronics, robotics, manufacturing. $250K ($150K cash + $100K in-kind) for 10%. 6 months. Shenzhen, SF, Newark, Tokyo. IndieBio: biotech, food tech, materials, therapeutics. $525K for 8-10%. 4-5 months. SF (flagship) and NYC. Chinaccelerator: fintech, e-commerce, edtech for Asia market entry. 6 months. MOX: mobile internet, cross-border scaling. Asia-focused. dlab: Web3 infrastructure. Up to $250K. Fully remote. Spun out 2024.

Value and support

First check in deep tech. Multi-stage from pre-seed through Series B. 60 pre-seed investments + 150 follow-on annually. Proprietary ACE (Accelerator Contract for Equity) instrument. Tens of thousands of sq ft of in-house labs and fabrication facilities. HAX Newark: 35,000 sq ft (opened April 2024). IndieBio SF: full wet lab. Weekly strategy calls, assigned mentors, 2,000+ alumni network, $500K+ partner perks. Grant writing, tech transfer, IP support.

Event focus

SOSV is a venture capital firm that focuses on investing in deep tech startups, particularly at the pre-seed stage. The firm emphasizes human and planetary health, aiming to support startups that address significant global challenges. SOSV invests in various sectors, including climate tech, human health, physical AI, critical minerals, and sustainable fashion.

Format narrative

SOSV operates several programs, including HAX, which focuses on hard tech startups, and IndieBio, a life sciences accelerator. These programs provide funding, resources, and hands-on support to help founders develop their companies.

Participant value

SOSV provides resources and funding to early-stage startups, helping them to develop innovative solutions for pressing global issues. With a focus on deep tech, the firm aims to foster advancements that benefit both humanity and the planet.

Editorial focus

SOSV is a multi-stage venture capital firm that invests in deep tech startups, focusing on human and planetary health. The firm operates two primary programs: HAX for hard tech startups and IndieBio for life sciences. SOSV typically invests up to $550,000 in pre-seed stage companies and supports them through development programs that provide technical, product, and company-building expertise.

Audience value

SOSV provides deep tech startups with initial investments and comprehensive support through development programs, enhancing their chances of success in the market.